Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population
Clinical trial NCT02236052 · COMPLETED
Trial details
- NCT number
- NCT02236052
- Sponsor
- Medicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-16
- Primary completion
- 2015-06-17
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.